(CercleFinance.com) – Oddo maintains its ‘outperformance’ rating on the Carbios share, with an unchanged price target of 45 euros.
The analysis office recalls that Carbios announced this morning the finalization of a long-term partnership with Novozymes for the supply of enzymes on an industrial scale.
Novozymes will produce and distribute the enzymes to Carbios licensees. ‘This important step forward for the group will allow the scalability of the Carbios model which is intended to be asset light’, indicates Oddo.
The analyst believes that this announcement is “very good news” and that it “confirms the interest of the Carbios solution in the world of plastic recycling”.
In this context, ‘the group should give slightly more precise guidance when presenting its annual results in early April’, suggests the broker.
Copyright © 2023 CercleFinance.com. All rights reserved.
The information and analyzes disseminated by Cercle Finance only constitute a decision-making aid for investors. The responsibility of Cercle Finance cannot be held directly or indirectly following the use of information and analyzes by readers. It is recommended that any uninformed person consult a professional adviser before any investment. This indicative information does not in any way constitute an incitement to sell or a solicitation to buy.
Did you like this article ? Share it with your friends with the buttons below.
